gershenwald
gershenwald
Неизвестная организация
Подтвержден адрес электронной почты в домене mdanderson.org
Название
Процитировано
Процитировано
Год
AJCC cancer staging manual
S Edition, SB Edge, DR Byrd
AJCC cancer staging manual, 2017
49652017
Final version of 2009 AJCC melanoma staging and classification
CM Balch, JE Gershenwald, S Soong, JF Thompson, MB Atkins, DR Byrd, ...
Journal of clinical oncology 27 (36), 6199, 2009
49132009
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
CM Balch, AC Buzaid, SJ Soong, MB Atkins, N Cascinelli, DG Coit, ...
Journal of Clinical Oncology 19 (16), 3635-3648, 2001
31302001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system
CM Balch, SJ Soong, JE Gershenwald, JF Thompson, DS Reintgen, ...
Journal of clinical oncology 19 (16), 3622-3634, 2001
27202001
A landscape of driver mutations in melanoma
E Hodis, IR Watson, GV Kryukov, ST Arold, M Imielinski, JP Theurillat, ...
Cell 150 (2), 251-263, 2012
23492012
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ...
Science 359 (6371), 97-103, 2018
20322018
The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging
MB Amin, FL Greene, SB Edge, CC Compton, JE Gershenwald, ...
CA: a cancer journal for clinicians 67 (2), 93-99, 2017
19052017
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
17042015
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
16712018
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
JE Gershenwald, W Thompson, PF Mansfield, JE Lee, MI Colome, ...
Journal of Clinical Oncology 17 (3), 976-976, 1999
13511999
Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ...
CA: a cancer journal for clinicians 67 (6), 472-492, 2017
1232*2017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
12182018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
11202018
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with …
MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ...
European journal of cancer 47 (1), 8-32, 2011
10272011
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
10172018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
9912018
Loss of PTEN promotes resistance to T cell–mediated immunotherapy
W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ...
Cancer discovery 6 (2), 202-216, 2016
9152016
Completion dissection or observation for sentinel-node metastasis in melanoma
MB Faries, JF Thompson, AJ Cochran, RH Andtbacka, N Mozzillo, ...
New England Journal of Medicine 376 (23), 2211-2222, 2017
8932017
NRAS mutation status is an independent prognostic factor in metastatic melanoma
JA Jakob, RL Bassett Jr, CS Ng, JL Curry, RW Joseph, GC Alvarado, ...
Cancer 118 (16), 4014-4023, 2012
6542012
Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade
PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ...
Cancer discovery 6 (8), 827-837, 2016
6272016
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20